Drugs of Congestive heart failure Flashcards

1
Q

CONGESTIVE HEART FAILURE(CHF)
- Occurs when ———— (———-) is inadequate
to provide —————-needed by the body.
CO = ——-(rate of contraction of heart) X ———–
(volume of blood ejected with each beat).

A

cardiac output(CO)
o2
HR X SV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HF occurs due to ———-cardiac
contractility or ———– preload and/or
afterload.

A

decreased-increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The patient has:

  • Low COP manifestations e.g., —-,—–,—-,—-,—-
  • Congestive manifestations e.g.,
  • —,—–,—-,—-,——
A

fatigue,
dizziness, cold hands, cyanosis, and syncope
leg oedema, congested liver, cough, dyspnea,
and pulmonary oedema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiac performance is a function of four
primary factors: ========,=======,=========,======
‡ ————: load on the heart created by the volume
of blood injected in the left ventricle (at the end of
diastole). It is a volume load.
‡ ———–: load on the contractile ventricle
created by the resistance to the blood injected into
the arterial system by the left ventricle i.e. total
peripheral resistance. Thus, it is a pressure load.
‡ ———–: the capacity of myocardial to
generate force to respond to preload and
overcome after load.
‡ ———–: a major determinant of cardiac output

A
Preload, after load, contractility&
heart rate (HR)
Preload
After load
Contractility
Heart rate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
-------------- blockers directly
affect the sympathetic
activity also it reduces
both preload and
afterload by working
on the kidney (inhibits
Renin release)
A

Beta1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
First we decrease
both preload and
afterload then we
work on the heart
activity(by-----------)
A

Digitalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathophysiogy of heart failure:
‡ They provide short term hemodynamic compensation for decreased CO but ultimately cause deterioration of
decompensated HF
1————- sympathetic activity:
‡ a- ———- Force of contraction
‡ b- ———–Heart rate
‡ c ————— of RAAS leads to : Vasoconstriction:
Venoconstriction————-preload
Arterioloconstriction————– afterload
2-Activation of RAAS: -
a-stimulate aldosterone ——-salt &water retention lead
——-preload
B- ————– of the heart & blood vessels.
C -Angiotensin II lead to VC ———preload &after load
3- Myocardial ————–

A
inc
inc
inc
stimulation
inc
inc
Remodeling
inc
hypertrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Functional classification
‡ Generally relies on the New York Heart
Association functional classification. The classes
(I-IV) are:
‡ Class I: no limitation is experienced in any
activities; there are ——— from ordinary
activities.
‡ Class II: ————-, mild limitation of activity; the
patient is comfortable at rest or with mild
exertion.
‡ Class III: marked limitation of any activity; the
patient is comfortable only ————–
‡ Class —-: any physical activity brings on
discomfort and symptoms occur at rest.

A

no symptoms
slight
at rest.
IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Therapeutic strategies:
‡ ————– physical activity
‡ ———- sodium intake
‡ treatment of comorbid conditions
‡ Use of diuretics,ACEIs &inotropic agents
‡ Avoid ———-,———-,——-, some drugs

A

Decrease
Decrease
NSAIDs,CCBs,alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chronic failure is best treated with ——– (———–) plus an —–, if tolerated, a ——–. Digitalis may be helpful if
systolic dysfunction is prominent.
- acute heart failure should be treated with a ——-; if severe, a prompt-acting positive inotropic agent
such as a———– or—————,
and ————– should be used as required to optimize
filling pressures and blood pressure.

A

diuretics(often loop agent plus spironolactone)+ ACE inhibitor- beta blocker-Digitalis

loop diuretic
beta agonist
phosphodiesterase inhibitor
vasodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drugs used in heart failure :
Drugs reduce mortality working on remodeling
3 drugs
ABS

A
  • ACEIs
  • Beta blockers
  • Spironolactone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Drugs used in heart failure :

-Drugs improve symptoms

A
  • Digitalis(Digoxin)
  • Diuretics
  • Vasodilators (nitrates or hydralazine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

———— is the most effective drug in
treatment of H.F it decreases both
preload and afterload and prevents
deterioration of the heart.

A

ACE-I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
Angiotensin converting enzyme
inhibitors(ACEIs) e.g. captopril:
- Mechanism of action:
 Pharmacokinetics:
_Incompletely absorbed, must be taken on empty stomach (food decreased absorption).
_ -Excreted by ------------
A

Decreased Angiotensin II production& NE
release leading to:
‡ 1- Decreased preload &after load.
‡ 2- Decreased cardiac hypertrophy, dilatation
&remodeling.
‡ 3- Decrease HR or does not increase it.

empty
kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Adverse effects of ACEI:

7 things

A

1 - First dose hypotension (start with a small
dose at bed time).
2 -Acute angioedema & chronic dry cough (inc
BK).
3 -Hyperkalemia (potassium supplement or
spironolactone are CI).
4 -Renal impairment (in renal artery stenosis,
high renin states as CHF).
5 -Metallic taste (captopril), neutropenia in some
cases.
6 -Fetotoxic (CI in pregnancy).urinary abnormality
7-CI in Asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Angiotensin II type ———– receptor
blockers(ARBs):
‡ ———— is the prototype and differs from other
in that it ———– extensive 1st pass
metabolism.
‡ Mechanism of action:
‡ antagonizing angiotensin II ____———-preload and afterload
‡ Block AT1 receptors ____ vasodilatations
&antiproliferative action.
No increase in ————– so no
angioedema &cough.
Adverse effects: same as ACEIs
CI in ——————.

A
1
Losartan
undergoes
decrease
bradykinines
pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2-Diuretics:
1 -Decrease blood volume ——–venous
return———- preload.
2 -Decrease CO————blood pressure ——–after
load
3 ————— are used in mild to moderate
cases while ———- diuretics are used in
sever, acute or in renal impairment

A

dec-dec-dec-dec
Thiazide
loop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

3- Beta blockers:
three members are recommended for use:
————, —————- and ————–.

A

carvedilol, bisoprolol and metoprolol

19
Q

Alpha and Beta blocker with antioxidant activity ?

A

Carvedilol

20
Q

Beta Blocker
Beneficial actions in——– mortality and
morbidity is due to; prevention of changes
due to chronic ————
stimulation,including ———– in
HR,inhibition of ———– release,———— of
deleterious effects of norepinephrine,
decreasing ————-,hypertrophy and cell
death (apoptosis).
used in ———– stages
Not given to ———— HF

A
reducing
sympathetic
decrease
renin
prevention
remodelling
acute
21
Q

Inotropic agents:
The only oral positive inotropic drug
available for chronic use

A

Digitalis or cardiac glycosides (digoxin):

22
Q

Digitalis or cardiac glycosides (digoxin):

Mechanism of myocardial contraction:

A
  • The force of contraction is directly
    proportional to the concentration of free
    intracellular (IC) calcium.
  • The amount of calcium sequestered in the SR
    is dependent on the balance of calcium influx
    and calcium efflux.
23
Q
  • Mechanism of action of digitalis:
    A-Mechanical: Inhibits membrane bound Na+/K+
    ATPase_————— IC Na+ thus concentration gradient
    across the membrane ————– _____decrease the
    driving force for the Na+/Ca++ exchanger ___ decrease
    calcium expulsion and ——–IC Ca++
    -The concentration gradient for—— and ——- is the
    major determinant of the net movement of ions
    especially ———-.
    -The increased IC Na+ and Ca++ results in:
  • 1-increased myocardial contractility____—— EDV &_____ CO,
    tissue & renal perfusion ____—- renin secretion ____——— salt&water retention &induce diuresis___——- preload and after
    load.
  • 2- Decrease sympathetic activity____—– HR, oxygen
    demand, VC& renin secretion.
A
increase
decreases
increase 
Na+ and Ca++
Na+
dec
inc
dec
dec
dec
dec
24
Q

B- Electrical: autonomic stimulation (mainly
————–, sympathetic only in ———–
doses) decreasing HR which is a sign of
improvement
‡ Therapeutic uses: ———– with AF (due to
combined inotropic & bradycardic
effect).Also, sever HF after ACEIs, BBlocker &
diuretics. Mild to moderate cases do not
require————-.
‡ —————is an early sign of
improvement.

A
parasympathetic
toxic
HF
digoxin
Bradycardia
25
‡ Pharmacokinetics: ‡ ---------- has rapid onset &shorter duration compared to digitoxin. ‡ -Has a high volume of distribution, used in acute digitalization. ‡ -Widely distributed including CNS, eliminated (2/3) unchanged through kidney(dose adjustment is needed). ‡ ----------- is extensively metabolized via liver. ‡ -Narrow safety margin.
Digoxin - digitoxin
26
patient has a kidney dysfunction can use ? ------------- metabolized by --------------
Digitoxin
27
patient has a live dysfunction can use ? ------------- metabolized by --------------
Digoxin
28
Digoxin CI | Absloute in
Ventricular arrhythmia Hypertrophy obstructive cardiomyopathy (thickening intraventrieular septum) -Never give +ve inotropes or +ve chronotropes Wolf Parkinson's white syndrome H-Block (-ve AV conduction) delay
29
Digoxin CI | relative in
``` Patients with Brndycardia On beta blockers On Verapamil Myodema= Hypothyroidism Sick sinus syndrome (Low SA node rate) Hyperactive carotid sinus ``` Systemic or Pulmonary H TN So, give VD first before Digoxin such C.C B ( not verapamil nor nifedipine) ive Amlodipine NO brady,c NO Tachy_ C Renal impairment (Digoxin toxicity) Cardiovesion (arrhythmia) MI (Increase infarct size) Acute rheumatic fever myocarditis
30
Digitalis or cardiac glycosides (digoxin): ‡ Adverse effects: 4 things
``` ‡ 1- Cardiac dysrhythmias: all types can be encountered: ‡ (Increased automaticity, and increased vagal tone). ‡ 2-GIT(Early early sign of Toxcity): nausea, vomiting &diarrhea . ‡ 3- CNS(late late sign of Toxcity): confusion, hallucinations, convulsions& colored vision(green and yellow) ‡ 4- Gynecomastia due to its steroid nucleus. ```
31
Treatment of toxicity of Digitalis: | 5 things
1 -Drug withdrawal with symptoms suggestive of toxicity (GIT& visual). 2 -Potassium supplement (CI in heart block, renal impairment). (K & digoxin inhibit each binding to ATPase). 3 -Antidysrhythmic drugs to treat dysrhythmia. 4 - Digoxin immune fab (antibodies) which inactivate the drug. 5 -Plasma pheresis: in renal failure since digoxin AB can not be given as they would accumulate.
32
--------------vs Digitalis
POTASSIUM
33
- Factors predisposing to digitalis toxicity: | 4 things
``` 1-Hypokalemia (K-losing diuretics &corticosteroids), hypercalcemia, hypomagnesaemia (magnesium opposes calcium). 2-Antidysrhythmic drugs: verapamil, amiodarone and quinidine ĺ displace digoxin from tissues &compete for excretion. 3- Hypothyroidism and hypoxia. 4- Renal impairment ```
34
cGMP > ---------- | cAMP > --------------+----------------
V.D V.D in Smooth ms , V.C in myocardial ma
35
Other positive inotropic agents:
1- Beta adrenoceptors agonists: (direct)(emergency)a-Dobutamine: used in acute HF& given by IV infusion (inc.cAMP___ phosphorylation of calcium channels____ inc calcium entry into myocardium and VD). b-Dopamine: inc CO, inc renal blood flow &inc blood pressure (depending on the dose_ stimulate dopamine, beta or alpha receptors) 2-Phosphodiesterase inhibitors(indirect): Amrinone &milrinone ___inc cAMP_____incIC calcium___-inc myocardial contractility. -Indicated for short term therapy___ rapid tolerance, thrombocytopenia& hepatotoxicity.
36
It causes smooth muscle relaxation, and increases heart contractility-------------
-Phosphodiesterase inhibitors
37
Used in acute HF or cardiogenic shock-----------
Dobutamine
38
use only with acute CHF , for maximum 48h | -----------
Phosphodiesterase inhibitors:
39
Spironolactone: -Small dose added to---,-----,---- _ decrease mortality by 30% due to prevention of ----------- production__ decrease salt and water retention. Also, counteracts ------------- which predisposes to digitalis toxicity & decreases remodeling. -Should not be taken with --------------- or in -----------------.
``` ACEIs, diuretics& digoxin-aldosterone hypokalemia potassium renal impairment ```
40
6- Vasodilators - ---------dilators as nitrates_dec preload by shifting blood to venous capacitance vessels (--------of whole vascular system) ĺ dec congestive symptoms. - Arteriolodilators: - e.g. hydalazine_ dec peripheral resistance dec after load _inc CO &tissue perfusion. ‡ Hydralazine should not be used alone (---------+-------) _combined with --------------------.
``` Veno 80% reflex tachycardia& edema nitrates ```
41
Management of Acute Heart Failure I. Management of Acute Pulmonary Edema ----------- IV, --------------- IV, ------------- IV, and Oxygen to control hypoxia II. Restoring Hemodynamics (----------COP & tissue perfusion and maintain BP): Drugs used differ according to level of the systolic BP: ------, -------, or -------.
``` Frusemide Nitroglycerin Morphine increase NE Dobutamine nitrates ```
42
Diastolic dysfunction ƒ CHF with preserved EF ƒ Is best treated with: β-blockers; ``` - Prevent tachycardia; Maximizing diastolic filling) - Reduce B.P and MI - Promote regression of LV Hypertrophy - Associated with improved survival Diuretics to reduce --------------- ```
preload
43
Beta blocker treatment should not be: • Prescribed without -------------in patients with current or recent history of fluid retention. • Prescribed to patients with higher degree AV heart block, and should be used with caution in those with second degree AV block. • Prescribed for initiation in patients with acute HF symptoms or ------------ HF. • If a non-cardioselective beta blocker (e.g., carvedilol)), prescribed to patients with significant asthma or bronchoconstrinction, especially if with a ------- methacholine challenge
diuretics decompensated positive